Combination treatment with erlotinib and pertuzumab against human tumor xenografts is superior to monotherapy (Q46610633)
Jump to navigation
Jump to search
scientific article published in July 2005
Language | Label | Description | Also known as |
---|---|---|---|
English | Combination treatment with erlotinib and pertuzumab against human tumor xenografts is superior to monotherapy |
scientific article published in July 2005 |
Statements
1 reference
Combination treatment with erlotinib and pertuzumab against human tumor xenografts is superior to monotherapy (English)
1 reference
Thomas Friess
1 reference
Werner Scheuer
1 reference
Max Hasmann
1 reference
1 July 2005
1 reference
11
1 reference
14
1 reference
5300-5309
1 reference